뼈 및 관절용 재생의료 시장

Highlights:

The global regenerative medicine for bone and joint applications market should reach $16.4 billion by 2027 from $9.4 billion in 2022 at a compound annual growth rate (CAGR) of 11.6% for the forecast period of 2022 to 2027.

The biomaterials technology segment of the global regenerative medicine for bone and joint applications market is expected to grow from $5.9 billion in 2022 to $10.2 billion in 2027 at a CAGR of 11.5% for the forecast period of 2022 to 2027.

The tissue engineering technology segment of the global regenerative medicine for bone and joint applications market is expected to grow from $2.3 billion in 2022 to $4.1 billion in 2027 at a CAGR of 12.0% for the forecast period of 2022 to 2027.

Report Scope:

The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.

This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.

The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases and others.

The report provides information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Report Includes:

• 51 tables
• An overview of the global market for regenerative medicines for bone and joint applications
• Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
• Characterization and quantification of market potential for regenerative medicines by technology, application, and region
• Coverage and discussion on regulatory delays due to COVID-19, clinical trials and product launches of the industry
• Description of principle approaches to regenerative medicine and discussion on importance of scaffolding in tissue engineering
• Information on major drivers and regional dynamics of the market and current trends within the industry
• Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
• Company profiles of major players, including Anika Therapeutics, Conmed Corp., Johnson & Johnson and Stryker Corp.

Table of Contents

Chapter 1 Introduction

• Background
• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Update?
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Overview of Regenerative Medicine
• How Regenerative Medicine Works
• Principal Approaches to Regenerative Medicine
• Cells and Tissues
• Tissue Engineering
• Importance of Scaffolding in Tissue Engineering
• Plastic Scaffolding
• Blood Vessel Scaffolding
• Center for Integration of Medicine and Innovative Technology (CIMIT)
• Embryonic Stem Cells

Chapter 4 Impact of COVID-19

• Overview
• Impact of COVID-19 on Cell and Gene Therapies, and Regenerative Medicine for Bone and Joint Applications
• Direct Impact on Clinical Trials in Cell and Gene Therapy

Chapter 5 Market Dynamics

• Market Drivers
• Rising Number of Bone and Joint Disorders and Orthopedic Surgeries
• Increasing Product Approvals and Launches
• R&D for Stem and Gene Therapies
• Market Restraints
• Stringent Government Regulatory Settings in R&D
• Market Opportunities
• Growing Pipeline for Regenerative Medicines
• Competitive Landscape

Chapter 6 Market Breakdown by Technology

• Global Market by Technology
• Biomaterials
• Biomaterials for Regeneration
• Market Size and Forecast
• Stem Cell Therapy
• Market Size and Forecast
• Tissue Engineering
• Market Size and Forecast

Chapter 7 Market Breakdown by Application

• Global Market by Application
• Allogeneic Bones
• Market Size and Forecast
• Autogenic Bones
• Market Size and Forecast
• Bone Graft Substitutes
• Market Size and Forecast
• Osteoarticular Diseases
• Market Size and Forecast
• Other Diseases
• Market Size and Forecast

Chapter 8 Market Breakdown by Region

• Global Market by Region
• North America
• United States
• Canada
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• Australia
• India
• Rest of Asia-Pacific
• Rest of the World

Chapter 9 Company Profiles

• ANIKA THERAPEUTICS INC.
• ARTHREX INC.
• BAXTER INTERNATIONAL INC.
• BIOVENTUS
• CONMED CORP.
• DEPUY SYNTHES PRODUCTS INC. (PART OF JOHNSON & JOHNSON)
• MEDTRONIC PLC
• SEIKAGAKU CORP.
• SMITH & NEPHEW PLC
• STRYKER CORP.
• ZIMMER BIOMET HOLDINGS INC.

Chapter 10 Appendix: List of Acronyms